PTC Therapeutics Promotes Matthew Klein, Eric Pauwels to C-Suite

Print Friendly, PDF & Email

Xconomy New York — Rare disease drug developer PTC Therapeutics (NASDAQ: PTCT ) has promoted Matthew Klein to chief development officer . Klein joined the South Plainfield, NJ, biotech last year as global head of gene and mitochondrial therapies. He was previously CEO and chief medical officer of BioElectron […]